Paul LaViolette

Paul brings over 33 years of global medical technology management experience.

Paul was most recently Chief Operating Officer at Boston Scientific Corporation (BSC), an $8 billion medical device leader. During his 15 years at BSC, he served as COO, Group President, President-Cardiology and President-International as the company grew revenues over 20 times. Paul integrated two dozen acquisitions and led extensive product development, operations and worldwide commercial organizations.

Paul previously held marketing and general management positions at CR Bard, and various marketing roles at Kendall (Covidien). He served on the boards of Urologix, Percutaneous Valve Technologies and Advamed and currently serves on the boards of *Baxano Surgical, *Cardiofocus, CardioKinetix, Coridea NC2, CSA Medical, *DC Devices, *Direct Flow Medical, Thoratec, *TransEnterix, ValenTx and the Medical Device Manufacturers Association (MDMA).

Paul received his BA in Psychology from Fairfield University and his MBA from Boston College.

Paul LaViolette is the Managing Partner, Chief Operating Officer at SV Health Investors, based in United States, North America. With a background in Venture Capital, Paul LaViolette has a rich history of leadership and innovation. Paul LaViolette studied BA Psychology @ Fairfield University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.